Accurate staging of lung cancer has a profound impact on patient management. For stage I nonsmall cell lung carcinomas (NSCLCs), the absence (stage IA) or presence (stage IB) of visceral pleural invasion represents a critical therapeutic branch point: patients with stage IB NSCLC benefit from adjuvant chemotherapy, whereas patients with stage IA NSCLC do not. Elastic staining has been advocated as a simple method for visualizing pleural invasion. The purpose of this study was to determine whether routine elastic staining of the resected peripheral NSCLCs alters tumor staging in a meaningful way. The study cases consisted of 100 consecutive peripheral NSCLCs resections that were pathologically staged as IA based on routine histologic assessment. Each case was stained with the Movats pentachrome elastic stain to aid identification of visceral pleural invasion. To assess current standards of surgical pathology practice, members of the American Association of Directors of Anatomic and Surgical Pathology were asked whether they never, sometimes, or always order elastic stains for peripheral NSCLCs that abut the pleura. Elastic staining resulted in a change of tumor stage from IA to IB in 19 (19%) cases. Of the 49 pathologists that responded to the survey, 25 (51%) never, 14 (29%) sometimes, and 10 (20%) always order an elastic stain for NSCLCs abutting the pleura. Elastic staining is currently not standard surgical pathology practice for the evaluation of peripheral NSCLCs, but it should be. Invasion of the pleura is an elusive finding that is best appreciated with an elastic stain. Our experience suggests that routine elastic tissue staining should be performed as a standard method of assessing pleural involvement for pleural-based nonsmall cell lung carcinomas.
Abstract: Accurate staging of lung cancer has a profound impact on patient management. For stage I nonsmall cell lung carcinomas (NSCLCs), the absence (stage IA) or presence (stage IB) of visceral pleural invasion represents a critical therapeutic branch point: patients with stage IB NSCLC benefit from adjuvant chemotherapy, whereas patients with stage IA NSCLC do not. Elastic staining has been advocated as a simple method for visualizing pleural invasion. The purpose of this study was to determine whether routine elastic staining of the resected peripheral NSCLCs alters tumor staging in a meaningful way. The study cases consisted of 100 consecutive peripheral NSCLCs resections that were pathologically staged as IA based on routine histologic assessment. Each case was stained with the Movats pentachrome elastic stain to aid identification of visceral pleural invasion. To assess current standards of surgical pathology practice, members of the American Association of Directors of Anatomic and Surgical Pathology were asked whether they never, sometimes, or always order elastic stains for peripheral NSCLCs that abut the pleura. Elastic staining resulted in a change of tumor stage from IA to IB in 19 (19%) cases. Of the 49 pathologists that responded to the survey, 25 (51%) never, 14 (29%) sometimes, and 10 (20%) always order an elastic stain for NSCLCs abutting the pleura. Elastic staining is currently not standard surgical pathology practice for the evaluation of peripheral NSCLCs, but it should be. Invasion of the pleura is an elusive finding that is best appreciated with an elastic stain. Our experience suggests that routine elastic tissue staining should be performed as a standard method of assessing pleural involvement for pleural-based nonsmall cell lung carcinomas. F or patients with resectable nonsmall cell lung carcinoma (NSCLC), tumor stage is a powerful predictor of long-term survival. Even so, tumor recurrence and death remain a significant threat even for patients with stage I tumors. On the basis of the information compiled between 1985 and 1995 in the National Cancer Database, approximately 40% of patients with resected stage I NSCLC die within 5 years of resection. 4 In 1997, the International Staging System was modified to underscore clear-cut survival differences among patients with stage I disease. 13 In particular, the relationship of the tumor to the visceral pleura was identified as a critical parameter in patient stratification. For patients with small NSCLCs (less than 3 cm), the absence of pleural invasion (stage IA) has been consistently associated with superior survival rates compared with the presence of pleural invasion (stage IB). 8, 12, 14, 15 The distinction between stages IA and IB has been helpful in identifying those patients most likely to benefit from adjuvant chemotherapy. Recently, several large randomized clinical trials have shown that the patients with stage IB disease significantly benefit from adjuvant chemotherapy, and those with stage IA disease do not. 10, 16, 19 Accordingly, chemotherapy in addition to surgery is now becoming standard of care for the patients with stage I NSCLCs that invade the visceral pleura. 11 Although most staging schemes have come to appreciate the importance of pleural invasion in the staging of NSCLC, their silence regarding the histologic parameters that qualify for pleural invasion has led to considerable ambiguity in the recognition and reporting of pleural invasion. The most detailed and widely used systems for classifying pleural invasion recognize the elastic lamina of the visceral pleura as the key histologic landmark. 7, 18 NSCLCs that penetrate this structure behave more aggressively than those that do not, even when these tumors do not extend all the way to the pleural surface. 3, 5, 8, 9, 15 Yet behind this apparent simplicity is the confounding fact that the elastic lamina is not a conspicuous finding by routine hematoxylin and eosin (H&E) staining. Consequently, the use of elastic stains has been advocated as an aid in recognizing disruption of the elastic lamina and, in turn, a means for more precise tumor staging. 2, 3, 5, 8, 15 The purpose of the present study was to retrospectively assess the impact of elastic staining on tumor staging when applied to NSCLCs staged as IA based solely on interpretation of the H&E-stained slides.
METHODS

Cases
Study approval was obtained from the Johns Hopkins Medical Institutions Internal Review Board. The surgical pathology files of the Johns Hopkins Hospital were searched for consecutive patients beginning in 1986 that had undergone resections of NSCLCs that were pathologically staged as IA. Specifically, all of the tumors were less than 3 cm, and none invaded the visceral pleura as judged by histopathologic examination of H&Estained slides. The histologic slides were reviewed, and only those tumors that abutted the visceral pleura without intervening lung parenchyma were included for further analysis. A single representative block of the tumor periphery was selected from each of the 100 consecutive cases that met this criterion.
A Movats pentachrome stain was used to discern the presence and status of the elastic lamina of the visceral pleura. The elastic lamina was visualized as a black serpentine band of interconnecting fibers beneath the mesothelial layer ( Fig. 1 ). Cases were scored as positive for visceral pleura invasion (VPI) if the tumor transgressed the elastic lamina (Fig. 2 ). Cases were scored as negative for VPI if the tumor did not breach the elastic membrane, even if the tumors directly abutted the elastic lamina. Review of the elastic stains for the evaluation of VPI was independently performed by 2 lung pathologists (F.B.A. and W.H.W.).
To assess current standards of surgical pathology practice relating to pleural staging, a survey was distributed to members of the American Association of Directors of Anatomic and Surgical Pathology (ADASP). The ADASP was targeted, as this group is influential in setting standards for the processing and reporting of surgical pathology specimens. The directors were asked whether the practice of their laboratories was to ''never,'' ''sometimes,'' or ''always'' order an elastic stain to discern VPI for resected NSCLCs that abut the pleura without intervening lung parenchyma.
RESULTS
The 100 NSCLCs were comprised of 46 adenocarcinomas, 15 nonmucinous bronchioloalveolar carcinomas, 31 squamous cell carcinomas, 7 large cell undifferentiated carcinomas, and 1 adenosquamous carcinoma (Table 1 ). On the basis of the presence of visceral pleural invasion (VPI) as visualized by elastic staining, 19 (19%) tumors originally staged as T1 (stage IA) were restaged as T2 (stage IB). By histologic subtype, VPI was identified in 8 of 46 (17%) adenocarcinomas, 8 of 31 (26%) squamous cell carcinomas, 2 of 7 (28%) large cell undifferentiated carcinomas, and 1 of 1 (100%) adenosquamous cell carcinoma. Only the bronchioloalveolar carcinomas did not show evidence of VPI. Transgression of the visceral pleural elastic lamina by carcinoma was associated with consistent histologic features as highlighted by the Movats pentachrome stain: (1) the pleural visceral lamina was often accentuated in areas of VPI owing to thickening and compression of the elastic fibers;
(2) the fibroblastic stroma was increased as highlighted by zones of green staining surrounding the invasive tumor foci; and (3) the pleural visceral lamina was often sharply retracted into the underlying zones of desmoplastic stroma. In effect, VPI was seen as the presence of tumor foci within the arms of a conspicuous upright black ''V'' against a green background (Fig. 3) . Forty-nine pathologists responded to the survey distributed to members of the ADASP. All of the responders practiced surgical pathology within academic programs in the United States. When dealing with peripheral NSLCs that abut the pleura without intervening lung parenchyma, 25 (51%) indicated that they never use elastic stains, 14 (29%) sometimes use elastic stains, and 10 (20%) routinely order an elastic stain to assess VPI.
DISCUSSION
The visceral pleura is a composite structure comprised of a well-defined continuous elastic membrane, a thin fibroconnective tissue layer containing a rich lymphatic network, and a layer of mesothelial cells resting on a thin basement membrane. 1 The importance of the elastic lamina likely lays in its ability to bar tumor access to the subpleural lymphatics. Even for small peripheral adenocarcinomas between 1 and 2 cm, tumor transgression of the elastic membrane is strongly associated with metastatic spread to regional lymph nodes. 17 Exploitation of the pleural lymphatics as a means of cancer spread underlies the higher mortality rates associated with VPI for stage I NSCLCs, and explains why the presence of VPI is an important factor in distinguishing patients who may benefit from chemotherapy from those who may not.
Although the recognition of VPI is very important in guiding patient management, it is not very straightforward-at least not by routine microscopy. In their evaluation of 20 lung cancers that abutted the visceral pleura, Bunker et al 2 found that an elastic stain established VPI in 40% of the cases where its presence could not be identified by H&E staining alone. In their single lung cancer measuring less than 3 cm, elastic staining changed the tumor stage from T1 to T2, suggesting that routine elastic staining could enhance the accuracy of tumor staging for small peripheral lung carcinomas. In our evaluation of elastic staining, we focused exclusively on T1 peripheral lung cancers-the group of lung cancers where the subtle finding of VPI most powerfully impacts on tumor stage, patient management, and prognosis. Although VPI was reported as absent for all 100 of the study cases, VPI was identified by elastic staining in 19% of these carcinomas, changing the stage from T1 (stage IA) to T2 (stage IB). On exclusion of the bronchioloalveolar carcinomas, the frequency of VPI increased to 22%. Clearly, the routine use of an elastic stain to address the presence of pleural invasion will influence tumor staging in a significant percentage of small NSCLCs.
The need to provide accurate pleural staging has not, to this point, had much of an impact on long held surgical pathology attitudes and practices. In their survey of surgical pathology reporting of lung cancer resections, the College of American Pathologists noted that VPI was not even addressed in one-third of surgical pathology reports. 6 Gallagher et al 5 reported that elastic staining was used to assess pleural invasion in only 10% of peripheral lung cancers sent in consultation. 5 On the basis of our own survey, elastic staining of peripheral lung carcinomas is not routinely employed in the evaluation of peripheral lung cancers that abut the pleura, even among academic surgical pathologists influential in setting standards for the processing and reporting of surgical pathology specimens.
Changing trends in the treatment of stage IA and IB lung cancer no longer permit the dismissive attitude with which pleural status is generally addressed. Instead they demand a more thorough and systematic approach. The use of an elastic stain is a simple and widely available method to reliably discern the presence or absence of pleural invasion, and its routine use will result in more accurate tumor staging that may, in turn, help guide patient management. 
